FINANCIALS

AKBA Akebia Therapeutics Inc 1517022

Income Statement
Revenue	akba-20241231	37,428,000
Net Income	akba-20241231	-20,039,000
Profit Margin		-53.54%

Balance Sheet
Current Assets	100,120,000
Assets	207,142,000
Current Liabilities	65,709,000
Liabilities	257,544,000
Equity	-50,402,000
Shares Out	210,288,000

Cash Flow Statement
Operating Cash Flow	-36,193,000
Investing Cash Flow	-31,000

Market Analysis
Market Cap	292,300,594
Price	2.08
EPS	-0.20
PS	1.95
FCF	-36,224,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view AKBA documents filed with the SEC.

AKBA Filings Clear

View A List of Tickers